Luo Chunxu, Zou Lin, Sun Huijun, Peng Jinyong, Gao Cong, Bao Liuchi, Ji Renpeng, Jin Yue, Sun Shuangyong
College of Pharmacy, Dalian Medical University, Dalian, China.
Department of Internal Cardiovascular, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Front Pharmacol. 2020 Feb 28;11:153. doi: 10.3389/fphar.2020.00153. eCollection 2020.
Inflammatory diseases are caused by abnormal immune responses and are characterized by an imbalance of inflammatory mediators and cells. In recent years, the anti-inflammatory activity of natural products has attracted wide attention. Rosmarinic acid (RosA) is a water-soluble phenolic compound that is an ester of caffeic acid and 3, 4-dihydroxyphenyl lactic acid. It is discovered in many plants, like those of the Boraginaceae and Lamiaceae families. RosA has a wide range of pharmacological effects, including anti-oxidative, anti-apoptotic, anti-tumorigenic, and anti-inflammatory effects. The anti-inflammatory effects of RosA have been revealed through and studies of various inflammatory diseases like arthritis, colitis, and atopic dermatitis. This article mainly describes the preclinical research of RosA on inflammatory diseases and depicts a small amount of clinical research data. The purpose of this review is to discuss the anti-inflammatory effects of RosA in inflammatory diseases and its underlying mechanism.
炎症性疾病由异常免疫反应引起,其特征是炎症介质和细胞失衡。近年来,天然产物的抗炎活性引起了广泛关注。迷迭香酸(RosA)是一种水溶性酚类化合物,是咖啡酸与3,4-二羟基苯乳酸的酯。它在许多植物中都有发现,如紫草科和唇形科植物。RosA具有广泛的药理作用,包括抗氧化、抗凋亡、抗肿瘤和抗炎作用。RosA的抗炎作用已通过对关节炎、结肠炎和特应性皮炎等各种炎症性疾病的研究得以揭示。本文主要描述RosA对炎症性疾病的临床前研究,并呈现少量临床研究数据。本综述的目的是探讨RosA在炎症性疾病中的抗炎作用及其潜在机制。